{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:49:51Z","timestamp":1790027391299,"version":"4.0.1"},"reference-count":40,"publisher":"FapUNIFESP (SciELO)","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz. oral res."],"DOI":"10.1590\/1807-3107bor-2018.vol32.0093","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T06:16:02Z","timestamp":1537078562000},"source":"Crossref","is-referenced-by-count":12,"title":["Expression of urokinase-type plasminogen activator and its receptor in squamous cell carcinoma of the oral tongue"],"prefix":"10.1590","volume":"32","author":[{"given":"Marianna Sampaio","family":"SERPA","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio Grande do Norte,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Porpino","family":"MAFRA","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Norte,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salom\u00e3o Israel Monteiro Louren\u00e7o","family":"QUEIROZ","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Norte,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leorik Pereira da","family":"SILVA","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Norte,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9lia Batista de","family":"SOUZA","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Norte,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le\u00e3o Pereira","family":"PINTO","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Norte,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2018,9,13]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/156800909787314002","article-title":"a target for anti-cancer therapy","volume":"9","author":"Ulisse S","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"issue":"35","key":"ref2","doi-asserted-by":"crossref","first-page":"57351","DOI":"10.18632\/oncotarget.10344","article-title":"uPA\/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy","volume":"7","author":"Pav\u00f3n MA","year":"2016","journal-title":"Oncotarget"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1161\/STROKEAHA.110.595769","article-title":"Plasminogen activators in ischemic stroke: introduction","volume":"41","author":"Zoppo GJ","year":"2010","journal-title":"Stroke"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0033-1338127","article-title":"The apparent uPA\/PAI-1 paradox in cancer: more than meets the eye","volume":"39","author":"Kwaan HC","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jcpa.2015.07.003","article-title":"Immunohistochemical Detection of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor in Canine Vascular Endothelial Tumours","volume":"153","author":"Anwar S","year":"2015","journal-title":"J Comp Pathol"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/med.21308","article-title":"Involvement of urokinase-type plasminogen activator system in cancer: an overview","volume":"34","author":"Mekkawy AH","year":"2014","journal-title":"Med Res Rev"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/ijc.26382","article-title":"Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry","volume":"131","author":"Laerum OD","year":"2012","journal-title":"Int J Cancer"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-269","article-title":"Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study","volume":"14","author":"Boonstra MC","year":"2014","journal-title":"BMC Cancer"},{"issue":"6","key":"ref9","first-page":"1555","article-title":"Expression of urokinase-type plasminogen activator\/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: association with mode of invasion and clinicopathological factors","volume":"26","author":"Yoshizawa K","year":"2011","journal-title":"Oncol Rep"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0714.2010.00953.x","article-title":"Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue cancer by immunohistochemistry","volume":"40","author":"Zhang Z","year":"2011","journal-title":"J Oral Pathol Med"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101895","article-title":"Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC)","volume":"9","author":"Magnussen S","year":"2014","journal-title":"PLoS One"},{"issue":"4-5","key":"ref12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","article-title":"Global epidemiology of oral and oropharyngeal cancer","volume":"45","author":"Warnakulasuriya S","year":"2009","journal-title":"Oral Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1834-7819.2010.01200.x","article-title":"Oral mucosal malignancy and potentially malignant lesions: an update on the epidemiology, risk factors, diagnosis and management","volume":"55","author":"McCullough MJ","year":"2010","journal-title":"Aust Dent J"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.oraloncology.2010.06.006","article-title":"Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I)","volume":"46","author":"Bello IO","year":"2010","journal-title":"Oral Oncol"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijom.2014.01.014","article-title":"Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases","volume":"43","author":"Rodrigues PC","year":"2014","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1601-0825.1998.tb00260.x","article-title":"Is the invasive front of an oral carcinoma the most important area for prognostication?","volume":"4","author":"Bryne M","year":"1998","journal-title":"Oral Dis"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1066896907304992","article-title":"Correlation of clinical, histological, and cytokeratin profiles of squamous cell carcinoma of the oral tongue with prognosis","volume":"15","author":"Silveira EJ","year":"2007","journal-title":"Int J Surg Pathol"},{"issue":"14","key":"ref18","doi-asserted-by":"crossref","first-page":"9450","DOI":"10.1074\/jbc.M501901200","article-title":"Urokinase-type plasminogen activator receptor regulates a novel pathway of fibronectin matrix assembly requiring Src-dependent transactivation of epidermal growth factor receptor","volume":"281","author":"Monaghan-Benson E","year":"2006","journal-title":"J Biol Chem"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3892\/ol.2013.1635","article-title":"Snail mediates invasion through uPA\/uPAR and the MAPK signaling pathway in prostate cancer cells","volume":"6","author":"Randle DD","year":"2013","journal-title":"Oncol Lett"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1083\/jcb.200701092","article-title":"uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells","volume":"178","author":"Lester RD","year":"2007","journal-title":"J Cell Biol"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1365-2559.2011.04013.x","article-title":"An immunohistochemical analysis-based decision tree model for estimating the risk of lymphatic metastasis in pN0 squamous cell carcinomas of the lung","volume":"59","author":"Liu Y","year":"2011","journal-title":"Histopathology"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/0194599813496374","article-title":"Urokinase plasminogen activator and its inhibitor type-1 as prognostic factors in differentiated thyroid carcinoma patients","volume":"149","author":"Herceg GH","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10517-010-0943-y","article-title":"Urokinase and tissue plasminogen activators and their PAI-1 inhibitor in tumors of patients with oral mucosal cancer: relationship with the main clinical morphological factors","volume":"149","author":"Gershtein ES","year":"2010","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1368-8375(97)00028-6","article-title":"Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis","volume":"34","author":"Nozaki S","year":"1998","journal-title":"Oral Oncol"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1348-8643(07)80010-3","article-title":"Expression of urokinase-type plasminogen activator (uPA), uPA receptor, and plasminogen activator inhibitor-1 in oral squamous cell carcinoma","volume":"4","author":"Inoue Y","year":"2007","journal-title":"Oral Sci Int"},{"issue":"2","key":"ref26","first-page":"181","article-title":"Correlation between TNM classification and malignancy histological feature of oral squamous cell carcinoma","volume":"71","author":"Costa ALL","year":"2005","journal-title":"Rev Bras Otorrinolaringol (Engl Ed)"},{"issue":"S1","key":"ref27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12070-014-0787-2","article-title":"Prognostic and predictive factors in gingivo buccal complex squamous cell carcinoma: role of tumor budding and pattern of invasion","volume":"67","author":"Manjula BV","year":"2015","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3563-3","article-title":"Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer","volume":"17","author":"Christensen A","year":"2017","journal-title":"BMC Cancer"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-8-220","article-title":"Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study","volume":"8","author":"Bacchiocchi R","year":"2008","journal-title":"BMC Cancer"},{"issue":"16","key":"ref30","doi-asserted-by":"crossref","first-page":"10647","DOI":"10.1073\/pnas.152127499","article-title":"Urokinase plasminogen activator receptor: prognostic biomarker for endometrial cancer","volume":"99","author":"Memarzadeh S","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bjc.6604806","article-title":"Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases","volume":"100","author":"Kita Y","year":"2009","journal-title":"Br J Cancer"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bjoms.2007.04.021","article-title":"Plasminogen activator system in oral squamous cell carcinoma","volume":"45","author":"Baker EA","year":"2007","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/path.2282","article-title":"Cancer invasion and metastasis: changing views","volume":"214","author":"Duffy MJ","year":"2008","journal-title":"J Pathol"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1096\/fasebj.14.10.1400","article-title":"A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo","volume":"14","author":"Guo Y","year":"2000","journal-title":"FASEB J"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygyno.2005.05.023","article-title":"A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial","volume":"99","author":"Berkenblit A","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ygyno.2008.06.028","article-title":"A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer","volume":"111","author":"Ghamande SA","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ijc.20192","article-title":"Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator system","volume":"110","author":"Ertongur S","year":"2004","journal-title":"Int J Cancer"},{"issue":"2 s2","key":"ref38","first-page":"20","article-title":"The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma","volume":"3","author":"Meyer JE","year":"2008","journal-title":"Breast Care (Basel)"},{"issue":"15","key":"ref39","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1073\/pnas.150239497","article-title":"A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin","volume":"97","author":"Mishima K","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/bjc.2013.62","article-title":"Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer","volume":"108","author":"Heinemann V","year":"2013","journal-title":"Br J Cancer"}],"container-title":["Brazilian Oral Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bor\/v32\/1807-3107-bor-32-e093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T07:08:45Z","timestamp":1537427325000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1806-83242018000100266&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,13]]},"references-count":40,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2018]]}},"alternative-id":["S1806-83242018000100266"],"URL":"https:\/\/doi.org\/10.1590\/1807-3107bor-2018.vol32.0093","relation":{},"ISSN":["1807-3107","1806-8324"],"issn-type":[{"value":"1807-3107","type":"electronic"},{"value":"1806-8324","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,13]]}}}